PIVKA-II level is correlated to development of portal vein tumor thrombus in patients with HBV-related hepatocellular carcinoma
Tao Li(Zhejiang Normal University), Jinhua Hu(Shandong University), Yi Cui(Kunming University of Science and Technology), Xiangguo Tian(Shandong University), Shaocan Tang(Shandong University), Jingfang Zhao(Fudan University Shanghai Cancer Center), Yuanzi Yu(Shandong University), Juan Liu(Shandong University), Lei Wu(Shandong University), Meng Kong(Shandong University), Shengqing Gu(Dana-Farber Cancer Institute)
Cited by 21
Related Papers
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer
|JAMA Oncology|2017|603
Martensitic transformation and shape memory effect in ferromagnetic Heusler alloy Ni2FeGa
|Applied Physics Letters|2003|272
Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial
|The Lancet. Gastroenterology & hepatology|2019|230
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer
|Cancer Research|2020|215
The Immune Subtypes and Landscape of Squamous Cell Carcinoma
|Clinical Cancer Research|2019|206